Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* infants coming to their own child health center before the age of 13 weeks, and judged to be in good health on the basis of medical history and physical examination~* family living permanently in Tampere, Kangasala or Nokia~* at least one of the parents/guardians is able to communicate fluently in Finnish~* written informed consent obtained from a parent/guardian prior to enrollment in the study~Exclusion Criteria:~* hypersensitivity to any of the components of the vaccines used in the study,~* known or suspected impairment of immunologic function,~* history of invasive pneumococcal disease,~* prior vaccination with any pneumococcal vaccine,~* prior vaccination with hepatitis B vaccine,~* contraindications to routine childhood immunizations~* any medical condition in which, in the opinion of the investigator, the study procedures or vaccinations might cause risk to the health or endanger the well-being of the child

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 12 Weeks
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).